← Back to headlines
Analysts Offer Mixed Views on Pfizer Stock
Financial analysts are presenting varied perspectives on Pfizer (PFE) stock, with some expressing bullish sentiment and recommending it as a strong investment. Others, like Morgan Stanley, maintain an "Equal Weight" rating due to patent concerns, while still considering it among the best medical stocks.
30 Apr, 22:33 — 1 May, 11:05
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left2
Left (2)
globe-and-mailYahoo
Center
Right
Far R
Geographic diversity— 2 regions9/34
Canada1US1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
globe-and-mailHigh104d ago
Analysts Are Bullish on These Healthcare Stocks: Teladoc (TDOC), Pfizer (PFE) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Teladoc (TDOC), Pfizer (PFE) The Globe and Mail
Read full article →YahooMostly Factual105d ago
Morgan Stanley Maintains Pfizer (PFE) at Equal Weight, Highlights Patent Concerns
Read full article →Coverage Timeline
First report: Yahoo · 30 Apr, 22:33|Full coverage: 2 · 13h|Window: 13h
Left-leaningCenterRight-leaning
